By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


NovoCure Ltd. 

Bridgeport  Connecticut  06610  U.S.A.
Phone: n/a Fax:


Medical Device

Company News
NovoCure Ltd. Enrolls The First Patient In Its Phase II STELLAR Trial Of Tumor Treating Fields Together With Pemetrexed And Cisplatin Or Carboplatin For The Treatment Of Malignant Mesothelioma 2/23/2015 10:25:14 AM
NovoCure Ltd. Announces The Completion Of Enrollment Of Its PANOVA Trial Of Tumor Treating Fields Plus Gemcitabine For Treatment Of Pancreatic Cancer 1/12/2015 10:41:32 AM
NovoCure Ltd. Announces $100 Million Term Loan Agreement With Pharmakon Advisors 1/8/2015 10:47:24 AM
NovoCure Ltd. Announces Optune Now Available At More Than 150 Leading Cancer Centers Across The United States 12/19/2014 10:16:39 AM
Electric Field Therapy Could Stop Tumor Growth In Brain Cancer, NovoCure Ltd. Reveals 12/3/2014 7:37:22 AM
Interim Analysis Of NovoCure Ltd.'s Phase 3 Trial In Newly Diagnosed Glioblastoma To Be Presented At Japan Society For Neuro-Oncology 2014 12/1/2014 8:49:29 AM
NovoCure Ltd. Announces The EF-14 Phase 3 Clinical Trial Of Tumor Treating Fields In Patients With Newly Diagnosed Glioblastoma Has Been Terminated At The Interim Analysis Due To Early Success 11/17/2014 8:59:07 AM
NovoCure Ltd. Announces The Presentation Of New Data At The 19th Annual Society Of Neuro-Oncology Meeting 11/11/2014 8:28:36 AM
NovoCure Ltd. Enrolls First Patient In A Pilot Study Of Tumor Treating Fields (TTFields) Together With Paclitaxel For The Treatment Of Recurrent Ovarian Cancer 10/30/2014 7:30:45 AM
NovoCure Ltd. Announces Recurrent Glioblastoma Patient Registry Dataset (PRide) To Be Presented At ESMO And EANO 2014 9/25/2014 8:09:38 AM